FacultyFaculty/Author Profile
Daniel L. Reisner

Daniel L. Reisner

Arnold & Porter

New York City, NY, USA


Daniel Reisner focuses on patent and trade secret litigation involving biotechnology, pharmaceuticals, ANDA filings, medical devices and telecommunications.

For over two decades Mr. Reisner has worked on numerous trials and has broad experience in all phases of litigation for a variety of clients including Pfizer, Novartis, GSK, Sanofi and Regeneron.  His cases have involved a multitude of therapeutics and devices including Celebrex, Viagra, Gleevec, cardiac monitoring and HCV detection.

Along with David Barr, Mr. Reisner has served as the co-editor and a principal author of Pharmaceutical and Biotech Patent Law.

Daniel L. Reisner is associated with the following items:
CHB Chapters  CHB Chapters Excerpt from Ch. 7: Types of Biological and Pharmaceutical Patents, Practising Law Institute, Pharmaceutical and Biotech Patent Law § 7:7 (November 2016) - Developments in Pharmaceutical and Biotech Patent Law 2017, Thursday, November 02, 2017
Excerpt from Ch. 5: Patentability, Practising Law Institute, Pharmaceutical and Biotech Patent Law § 5:4.5 [C] (November 2016) - Developments in Pharmaceutical and Biotech Patent Law 2017, Thursday, November 02, 2017
IPRs: Oil States, SAS, and Other Developments - Developments in Pharmaceutical and Biotech Patent Law 2018, Wednesday, October 31, 2018
MP3 Audio  MP3 Audio Antibody Patents: Obviousness, Written Description, Enablement and Other Challenges - Antibody Patents: Obviousness, Written Description, Enablement and Other Challenges, Thursday, November 02, 2017
Inter Partes Review: Oil States, SAS and Other Patent Law Developments - Inter Partes Review: Oil States, SAS and Other Patent Law Developments, Tuesday, October 30, 2018
MP4 - Mobile Video Seg  MP4 - Mobile Video Seg Antibody Patents: Obviousness, Written Description, Enablement and Other Challenges - Antibody Patents: Obviousness, Written Description, Enablement and Other Challenges, Thursday, November 02, 2017
Inter Partes Review: Oil States, SAS and Other Patent Law Developments - Inter Partes Review: Oil States, SAS and Other Patent Law Developments, Tuesday, October 30, 2018
Treatise Chapters  Treatise Chapters Patentability - Pharmaceutical and Biotech Patent Law, Friday, November 17, 2017
Utility and Patentable Subject Matter Requirements - Pharmaceutical and Biotech Patent Law, Friday, November 17, 2017
Biological Deposits - Pharmaceutical and Biotech Patent Law, Friday, November 17, 2017
Inventorship - Pharmaceutical and Biotech Patent Law, Friday, November 17, 2017
An Overview of Research & Development, Product Launch, and Patent Enforcement - Pharmaceutical and Biotech Patent Law, Friday, November 17, 2017
Types of Biological and Pharmaceutical Patents - Pharmaceutical and Biotech Patent Law, Friday, November 17, 2017
Web Segment  Web Segment Inter Partes Review: Oil States, SAS and Other Patent Law Developments - Developments in Pharmaceutical and Biotech Patent Law 2018, Tuesday, October 30, 2018
Transcripts  Transcripts Inter Partes Review: Oil States, SAS and Other Patent Law Developments - Inter Partes Review: Oil States, SAS and Other Patent Law Developments, Tuesday, October 30, 2018
Course Handbooks  Course Handbooks Developments in Pharmaceutical and Biotech Patent Law 2018
On-Demand Web Programs  On-Demand Web Programs Developments in Pharmaceutical and Biotech Patent Law 2018, Wednesday, November 07, 2018, New York, NY
Share
Email

  • FOLLOW PLI:
  • twitter
  • LinkedIn
  • YouTube
  • RSS

All Contents Copyright © 1996-2018 Practising Law Institute. Continuing Legal Education since 1933.

© 2018 PLI PRACTISING LAW INSTITUTE. All rights reserved. The PLI logo is a service mark of PLI.